Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr;56(4):898-907.
doi: 10.1161/STROKEAHA.124.047640. Epub 2025 Mar 10.

Associations Between Stroke Type, Ischemic Stroke Subtypes, and Poststroke Cognitive Trajectories

Affiliations

Associations Between Stroke Type, Ischemic Stroke Subtypes, and Poststroke Cognitive Trajectories

Deborah A Levine et al. Stroke. 2025 Apr.

Abstract

Background: It is unclear how poststroke cognitive trajectories differ by stroke type and ischemic stroke subtype. We studied associations between stroke types (ischemic and hemorrhagic), ischemic stroke subtypes (cardioembolic, large artery atherosclerotic, lacunar/small vessel, and cryptogenic/other determined causes), and poststroke cognitive decline.

Methods: We pooled participants from 4 US cohort studies (1971-2019). Outcomes were change in global cognition (primary) and changes in executive function and memory (secondary). Outcomes were standardized as T scores (mean [SD], 50 [10]); a 1-point difference represents a 0.1 SD difference in cognition. The median follow-up for the primary outcome was 6.0 (interquartile range, 3.2-9.2) years. Linear mixed-effects models estimated changes in cognition after stroke.

Results: We identified 1143 dementia-free individuals with acute stroke during follow-up: 1061 (92.8%) ischemic, 82 (7.2%) hemorrhagic, 49.9% female, and 30.8% Black. The median age at stroke was 74.1 (interquartile range, 68.6-79.3) years. On average, ischemic stroke survivors showed declines in global cognition (-0.35 [95% CI, -0.43 to -0.27] points/y; P<0.001), executive function (-0.48 [95% CI, -0.59 to -0.36] points/y; P<0.001), and memory (-0.27 [95% CI, -0.36 to -0.19] points/y; P<0.001). Poststroke declines in global cognition, executive function, and memory did not differ between hemorrhagic and ischemic stroke survivors. Differences in poststroke cognitive slope between hemorrhagic and ischemic stroke survivors were global cognition (0.02 [95% CI, -0.21 to 0.26] points/y; P=0.85), executive function (-0.13 [95% CI, -0.48 to 0.23] points/y; P=0.48), and memory (0.19 [95% CI, -0.05 to 0.43] points/y; P=0.12). On average, small vessel stroke survivors showed declines in global cognition (-0.33 [95% CI, -0.49 to -0.16] points/y; P<0.001), executive function (-0.44 [95% CI, -0.68 to -0.19] points/y; P<0.001), and memory (-0.19 [95% CI, -0.35 to -0.03] points/y; P=0.02). Poststroke cognitive declines did not differ between small vessel survivors and survivors of other ischemic stroke subtypes.

Conclusions: Stroke survivors had cognitive decline in multiple domains. Declines did not differ by stroke type or ischemic stroke subtype.

Keywords: blood pressure; cholesterol; cognition; glucose; stroke.

PubMed Disclaimer

Conflict of interest statement

Drs Levine, Aparicio, Gross, Briceño, Beiser, Seshadri, Romero, Hayward, Giordani, Springer, and Lazar report funding from the National Institutes of Health. Dr Levine reports personal fees from Northeastern University. Dr Aparicio reports compensation from the Alzheimer’s Association and grants from the American Academy of Neurology. Dr Pendlebury reports funding from the National Institute for Health Research Oxford Biomedical Research Centre. Dr Gottesman reports funding from the National Institute of Neurological Disorders and Stroke Intramural Research Program. Dr Sussman reports compensation from the State of Michigan Department of Health and Human Services for consultant services. Dr Lazar reports compensation from DiaMedica Therapeutics Inc for consultant services, compensation from EISAI INC for consultant services, and employment by the Department of Neurology, University of Alabama at Birmingham. Dr Springer reports travel support from Oregon Health and Science University. Dr Romero reports compensation from the Population Health Research Institute for data and safety monitoring services, service as Chair of Diversity, Equity and Inclusion committee for the American Stroke Association, and compensation from Brainomix for other services. Dr Fitzpatrick reports compensation from the National Institutes of Health Office of the Director for data and safety monitoring services. The other authors report no conflicts.

Update of

References

    1. Levine DA, Gałecki AT, Langa KM, Unverzagt FW, Kabeto MU, Giordani B, Wadley VG. Trajectory of cognitive decline after incident stroke. JAMA. 2015;314:41–51. - PMC - PubMed
    1. Pendlebury ST, Rothwell PM, Oxford Vascular Study. Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: Analysis of the population-based Oxford vascular study. Lancet Neurology. 2019;18:248–258. - PMC - PubMed
    1. Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM, Beaton AZ, Boehme AK, Buxton AE, et al. Heart disease and stroke statistics - 2023 update: A report from the American Heart Association. Circulation. 2023;147:e93–e621. - PubMed
    1. Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: A systematic review and meta-analysis. Lancet Neurol. 2009;8:1006–1018. - PubMed
    1. Levine DA, Wadley VG, Langa KM, Unverzagt FW, Kabeto MU, Giordani B, Howard G, Howard VJ, Cushman M, Judd SE, et al. Risk factors for poststroke cognitive decline: The REGARDS Study (Reasons for Geographic and Racial Differences in Stroke). Stroke. 2018;49:987–994. - PMC - PubMed